• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病心力衰竭患者尿素氮分数排泄率的应用。

Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease.

机构信息

Department of Cardiovascular Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Department of Health Care Administration, Nippon Medical School, Tokyo, Japan.

出版信息

ESC Heart Fail. 2023 Jun;10(3):1706-1716. doi: 10.1002/ehf2.14327. Epub 2023 Feb 23.

DOI:10.1002/ehf2.14327
PMID:36823779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10192260/
Abstract

AIMS

Maintenance of euvolaemia with diuretics is critical in heart failure (HF) patients with chronic kidney disease (CKD); however, it is challenging because no reliable marker of volume status exists. Fractional excretion of urea nitrogen (FEUN) is a useful index of volume status in patients with renal failure. We aimed to examine whether FEUN is a surrogate marker of volume status for risk stratification in HF patients with CKD.

METHODS AND RESULTS

We examined 516 HF patients with CKD (defined as discharge estimated glomerular filtration rate < 60 mL/min/1.73 m ) whose FEUN was measured at discharge (median age, 80 years; 58% male). The patients were divided into four groups according to quartile FEUN value at discharge: low-FEUN, FEUN ≤ 32.1; medium-FEUN, 32.1 < FEUN ≤ 38.0; high-FEUN, 38.0 < FEUN ≤ 43.7; and extremely-high-FEUN, FEUN > 43.7. FEUN was calculated by the following formula: (urinary urea × serum creatinine) × 100/(serum urea × urinary creatinine). During the 3 year follow-up, 131 HF readmissions occurred. Kaplan-Meier analysis showed that the HF readmission rate was significantly lower in the medium-FEUN group than in the other three groups (log-rank test, P = 0.029). Multivariate Cox regression analysis identified the low-FEUN, high-FEUN, and extremely-high-FEUN values as independent factors associated with post-discharge HF readmission. In the analysis of 130 patients who underwent right heart catheterization during hospitalization, a significant correlation between FEUN value and right atrial pressure was observed (R = 0.243, P = 0.005). Multivariate linear regression analysis revealed that FEUN value at discharge decreased in a dose-dependent manner with loop diuretics.

CONCLUSIONS

In HF patients with CKD, FEUN is a potential marker of volume status for risk stratification of post-discharge HF readmission. Low FEUN value (FEUN ≤ 32.1) may represent intravascular dehydration, whereas high FEUN value (FEUN > 38.0) may represent residual congestion; both of them were independent risk factors for HF readmission. FEUN may be useful to determine euvolaemia and guide fluid management in HF patients with CKD.

摘要

目的

在患有慢性肾脏病(CKD)的心力衰竭(HF)患者中,用利尿剂维持血容量正常至关重要;然而,由于没有可靠的容量状态标志物,这是一项具有挑战性的任务。尿素氮排泄分数(FEUN)是肾功能衰竭患者容量状态的有用指标。我们旨在研究 FEUN 是否可作为 HF 合并 CKD 患者风险分层的替代容量状态标志物。

方法和结果

我们检查了 516 例 CKD 合并 HF 患者(定义为出院时估计肾小球滤过率 < 60 mL/min/1.73 m ),他们在出院时测量了 FEUN(中位年龄 80 岁;58%为男性)。根据出院时 FEUN 值的四分位距将患者分为四组:低 FEUN 组,FEUN ≤ 32.1;中 FEUN 组,32.1 < FEUN ≤ 38.0;高 FEUN 组,38.0 < FEUN ≤ 43.7;极高 FEUN 组,FEUN > 43.7。FEUN 通过以下公式计算:(尿尿素 × 血清肌酐)× 100/(血清尿素 × 尿肌酐)。在 3 年的随访期间,有 131 例 HF 再入院。Kaplan-Meier 分析显示,中 FEUN 组的 HF 再入院率明显低于其他三组(对数秩检验,P = 0.029)。多变量 Cox 回归分析确定低 FEUN、高 FEUN 和极高 FEUN 值是与出院后 HF 再入院相关的独立因素。在对 130 例住院期间接受右心导管检查的患者进行的分析中,观察到 FEUN 值与右心房压之间存在显著相关性(R = 0.243,P = 0.005)。多变量线性回归分析显示,出院时 FEUN 值呈剂量依赖性下降。

结论

在 CKD 合并 HF 患者中,FEUN 是预测出院后 HF 再入院风险的潜在容量状态标志物。低 FEUN 值(FEUN ≤ 32.1)可能代表血管内脱水,而高 FEUN 值(FEUN > 38.0)可能代表残余充血;两者都是 HF 再入院的独立危险因素。FEUN 可能有助于确定 HF 合并 CKD 患者的血容量正常,并指导液体管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/e39aea38d8a7/EHF2-10-1706-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/5d2e9bf12c25/EHF2-10-1706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/532401636636/EHF2-10-1706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/7e430660eb25/EHF2-10-1706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/e39aea38d8a7/EHF2-10-1706-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/5d2e9bf12c25/EHF2-10-1706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/532401636636/EHF2-10-1706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/7e430660eb25/EHF2-10-1706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becc/10192260/e39aea38d8a7/EHF2-10-1706-g004.jpg

相似文献

1
Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease.慢性肾脏病心力衰竭患者尿素氮分数排泄率的应用。
ESC Heart Fail. 2023 Jun;10(3):1706-1716. doi: 10.1002/ehf2.14327. Epub 2023 Feb 23.
2
Fractional excretion of urea nitrogen can identify true worsening renal function in patients with heart failure.尿素氮的分数排泄可以识别心力衰竭患者真正的肾功能恶化。
ESC Heart Fail. 2024 Aug;11(4):2043-2054. doi: 10.1002/ehf2.14755. Epub 2024 Mar 24.
3
Prognostic Value of Fractional Excretion of Urea Nitrogen at Discharge in Acute Decompensated Heart Failure.急性失代偿性心力衰竭患者出院时尿素氮排泄分数的预后价值。
J Am Heart Assoc. 2021 Aug 17;10(16):e020480. doi: 10.1161/JAHA.120.020480. Epub 2021 Aug 7.
4
New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure.新的急性心力衰竭时尿素氮分数排泄和估计血浆容量状态联合评估分类。
J Am Heart Assoc. 2023 Jan 3;12(1):e025596. doi: 10.1161/JAHA.122.025596. Epub 2022 Dec 30.
5
Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.托伐普坦促进钠和尿素的尿排泄:一项回顾性队列研究。
Clin Exp Nephrol. 2018 Jun;22(3):550-561. doi: 10.1007/s10157-017-1475-9. Epub 2017 Oct 20.
6
Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure.尿素排泄分数在急性肾衰竭鉴别诊断中的意义。
Kidney Int. 2002 Dec;62(6):2223-9. doi: 10.1046/j.1523-1755.2002.00683.x.
7
Prognostic factors for one-year mortality in patients with acute heart failure with and without chronic kidney disease: differential impact of beta-blocker and diuretic treatments.伴有和不伴有慢性肾脏病的急性心力衰竭患者一年死亡率的预后因素:β受体阻滞剂和利尿剂治疗的不同影响。
Hypertens Res. 2019 Jul;42(7):1011-1018. doi: 10.1038/s41440-018-0204-4. Epub 2019 Jan 18.
8
Comparison between fractional excretions of urea and sodium in children with acute kidney injury.比较儿童急性肾损伤时尿素和钠的分数排泄率。
Pediatr Nephrol. 2009 Dec;24(12):2409-12. doi: 10.1007/s00467-009-1271-1.
9
Utility of fractional excretion of urea in the differential diagnosis of acute kidney injury in children.尿素排泄分数在儿童急性肾损伤鉴别诊断中的应用
Pediatr Nephrol. 2016 Aug;31(8):1349-53. doi: 10.1007/s00467-016-3366-9. Epub 2016 Mar 18.
10
Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease.托伐普坦对急性失代偿性心力衰竭合并慢性肾脏病患者的临床疗效
Heart Vessels. 2016 Oct;31(10):1643-9. doi: 10.1007/s00380-015-0775-9. Epub 2015 Nov 28.

引用本文的文献

1
Urine chloride trajectory and relationship with diuretic response in acute heart failure.急性心力衰竭中尿氯轨迹及其与利尿剂反应的关系
ESC Heart Fail. 2025 Feb;12(1):133-141. doi: 10.1002/ehf2.15054. Epub 2024 Oct 22.
2
Spot urine sodium-to-creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure.尿钠/肌酐比值优于钠在急性心力衰竭中识别利尿剂反应不良。
ESC Heart Fail. 2024 Oct;11(5):3438-3442. doi: 10.1002/ehf2.14883. Epub 2024 Jun 10.
3
Fractional excretion of urea nitrogen can identify true worsening renal function in patients with heart failure.

本文引用的文献

1
Lack of correlation between different congestion markers in acute decompensated heart failure.不同充血标志物与急性失代偿性心力衰竭之间缺乏相关性。
Clin Res Cardiol. 2023 Jan;112(1):75-86. doi: 10.1007/s00392-022-02036-9. Epub 2022 Jun 1.
2
Prognostic Value of Fractional Excretion of Urea Nitrogen at Discharge in Acute Decompensated Heart Failure.急性失代偿性心力衰竭患者出院时尿素氮排泄分数的预后价值。
J Am Heart Assoc. 2021 Aug 17;10(16):e020480. doi: 10.1161/JAHA.120.020480. Epub 2021 Aug 7.
3
Kidney Function and Outcomes in Patients Hospitalized With Heart Failure.
尿素氮的分数排泄可以识别心力衰竭患者真正的肾功能恶化。
ESC Heart Fail. 2024 Aug;11(4):2043-2054. doi: 10.1002/ehf2.14755. Epub 2024 Mar 24.
4
The Importance of Optimal Hydration in Patients with Heart Failure-Not Always Too Much Fluid.心力衰竭患者最佳水合状态的重要性——并非总是液体过多。
Biomedicines. 2023 Sep 30;11(10):2684. doi: 10.3390/biomedicines11102684.
心力衰竭住院患者的肾功能和结局。
J Am Coll Cardiol. 2021 Jul 27;78(4):330-343. doi: 10.1016/j.jacc.2021.05.002. Epub 2021 May 11.
4
Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients.利尿剂的使用和剂量与心力衰竭门诊患者结局的关系:一项纳入 96959 例患者的观察性研究的系统评价和荟萃分析。
Heart Fail Rev. 2022 Jan;27(1):147-161. doi: 10.1007/s10741-020-09995-z.
5
Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment.心力衰竭中的充血:对生理学、诊断和治疗的当代观察。
Nat Rev Cardiol. 2020 Oct;17(10):641-655. doi: 10.1038/s41569-020-0379-7. Epub 2020 May 15.
6
Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology.评估心力衰竭进程中的肾功能——欧洲心脏病学会心力衰竭协会立场声明。
Eur J Heart Fail. 2020 Apr;22(4):584-603. doi: 10.1002/ejhf.1697. Epub 2020 Jan 7.
7
Clinical implications of the blood urea nitrogen/creatinine ratio in heart failure and their association with haemoconcentration.心力衰竭血尿素氮/肌酐比值的临床意义及其与血液浓缩的关系。
ESC Heart Fail. 2019 Dec;6(6):1274-1282. doi: 10.1002/ehf2.12531. Epub 2019 Dec 9.
8
Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis.社区慢性心力衰竭患者的生存状况:系统评价和荟萃分析。
Eur J Heart Fail. 2019 Nov;21(11):1306-1325. doi: 10.1002/ejhf.1594. Epub 2019 Sep 16.
9
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.心力衰竭伴充血时利尿剂的应用——欧洲心脏病学会心力衰竭协会立场声明。
Eur J Heart Fail. 2019 Feb;21(2):137-155. doi: 10.1002/ejhf.1369. Epub 2019 Jan 1.
10
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.